StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
241710.KQ$71700.00+0.42%
Fair $71700.00+0.0%

241710.KQ

Cosmecca Korea Co., Ltd.

Consumer Defensive / Household & Personal ProductsKOSDAQ

$71700.00

+300.00 (+0.42%)

Fairly Valued+0.0%Fair Value $71700.00Fund rank 29/100 · Data gapFallback financials|
SA 54/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 23%

FCF escenarios

weak_data · normalized FCF $20.4B · quality 50.0/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 34/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 241710.KQLocal privado en este navegador · Cosmecca Korea Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$765.8B

P/E

16.9x

↑

EV/EBITDA

8.9x

↓

ROE

18.0%

↑

Gross Margin

24.7%

↓

Debt/Equity

0.68

↑
52-Week Range$71700
$39950$106400

TradingView lightweight chart

241710.KQ price, volumen y niveles de valoración

Último $71,700Periodo +129.4%
Fair value: $71,700

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+17.1%

FCF CAGR

—

FCF margin

-1.0%

FCF / Net income

-0.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $640.93B · net income $45.44B · FCF $-6.42B

2022-FY → 2025-FY

Gross margin

24.7%+8.4% pts

Operating margin

13.0%+10.4% pts

Net margin

7.1%+6.4% pts

FCF margin

-1.0%-2.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$640.93B$640.93B$524.33B$470.72B$399.40B
Net Income$45.44B$45.44B$42.80B$22.32B$2.66B
EBITDA$97.94B$97.94B$88.59B$66.89B$26.77B
EPS4255.004255.004007.002090.00249.00
Gross Margin24.7%24.7%23.7%22.8%16.3%
Operating Margin13.0%13.0%11.5%10.4%2.6%
Net Margin7.1%7.1%8.2%4.7%0.7%
Balance Sheet
Debt/Equity0.680.680.560.640.82
Current Ratio1.281.28———
Cash Flow
Free Cash Flow$-6.42B$-6.42B$20.43B$23.25B$4.91B
Returns
ROE18.0%18.0%19.6%13.2%1.8%
Valuation
P/E16.8516.8513.5818.5941.97
EV/EBITDA8.878.877.337.337.71
P/B3.033.032.662.450.76
Growth & Yield
Revenue Growth22.2%22.2%11.4%17.9%—
EPS Growth6.2%6.2%91.7%739.4%—
Dividend Yield0.5%0.5%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

14.3%

razonable

EPS terminal req.

$6362.18

Spread vs growth

-8.2%

5Y implied EPS CAGR

12.6%

razonable

EPS terminal req.

$7698.24

Spread vs growth

-6.4%

10Y implied EPS CAGR

11.3%

razonable

EPS terminal req.

$12398.09

Spread vs growth

-5.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +76.3%

Total return

+76.3%

Start / end P/E

10.2x → 16.9x

EPS bridge

4007.00 → 4255.00

Residual

+4.1%

EPS growth+6.2%
Multiple rerating+65.5%
Dividend+0.5%
Residual / FX / buybacks / cross-term+4.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.